 | • レポートコード：GIR-107A12137 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、CAR T細胞療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。CAR T細胞療法の種類別市場規模（同種異系、自家）、用途別市場規模（病院、がん研究センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・CAR T細胞療法の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Celgene (Juno Therapeutics)、Novartis、Gilead (Kite Pharma)、Pfizer、CARsgen Therapeutics、Autolus Therapeutics、Aurora BioPharma、Sorrento Therapeutics、Mustang Bio、Bluebird Bio、Collectis、Allogene Therapeutics、Celyad ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：同種異系、自家 ・用途別分析2016年-2026年：病院、がん研究センター、その他 ・CAR T細胞療法の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・CAR T細胞療法のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・CAR T細胞療法のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・CAR T細胞療法の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・CAR T細胞療法の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The CAR T-Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global CAR T-Cell Therapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global CAR T-Cell Therapy market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
CAR T-Cell Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Allogeneic
Autologous
Market segment by Application, can be divided into
Hospitals
Cancer Research Centers
Others
Market segment by players, this report covers
Celgene (Juno Therapeutics)
Novartis
Gilead (Kite Pharma)
Pfizer
CARsgen Therapeutics
Autolus Therapeutics
Aurora BioPharma
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Collectis
Allogene Therapeutics
Celyad
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of CAR T-Cell Therapy
1.2 Classification of CAR T-Cell Therapy by Type
1.2.1 Overview: Global CAR T-Cell Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global CAR T-Cell Therapy Revenue Market Share by Type in 2020
1.2.3 Allogeneic
1.2.4 Autologous
1.3 Global CAR T-Cell Therapy Market by Application
1.3.1 Overview: Global CAR T-Cell Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Cancer Research Centers
1.3.4 Others
1.4 Global CAR T-Cell Therapy Market Size & Forecast
1.5 Global CAR T-Cell Therapy Market Size and Forecast by Region
1.5.1 Global CAR T-Cell Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global CAR T-Cell Therapy Market Size by Region, (2016-2021)
1.5.3 North America CAR T-Cell Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe CAR T-Cell Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific CAR T-Cell Therapy Market Size and Prospect (2016-2026)
1.5.6 South America CAR T-Cell Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa CAR T-Cell Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 CAR T-Cell Therapy Market Drivers
1.6.2 CAR T-Cell Therapy Market Restraints
1.6.3 CAR T-Cell Therapy Trends Analysis
2 Company Profiles
2.1 Celgene (Juno Therapeutics)
2.1.1 Celgene (Juno Therapeutics) Details
2.1.2 Celgene (Juno Therapeutics) Major Business
2.1.3 Celgene (Juno Therapeutics) CAR T-Cell Therapy Product and Solutions
2.1.4 Celgene (Juno Therapeutics) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Celgene (Juno Therapeutics) Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis CAR T-Cell Therapy Product and Solutions
2.2.4 Novartis CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Gilead (Kite Pharma)
2.3.1 Gilead (Kite Pharma) Details
2.3.2 Gilead (Kite Pharma) Major Business
2.3.3 Gilead (Kite Pharma) CAR T-Cell Therapy Product and Solutions
2.3.4 Gilead (Kite Pharma) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Gilead (Kite Pharma) Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer CAR T-Cell Therapy Product and Solutions
2.4.4 Pfizer CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 CARsgen Therapeutics
2.5.1 CARsgen Therapeutics Details
2.5.2 CARsgen Therapeutics Major Business
2.5.3 CARsgen Therapeutics CAR T-Cell Therapy Product and Solutions
2.5.4 CARsgen Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 CARsgen Therapeutics Recent Developments and Future Plans
2.6 Autolus Therapeutics
2.6.1 Autolus Therapeutics Details
2.6.2 Autolus Therapeutics Major Business
2.6.3 Autolus Therapeutics CAR T-Cell Therapy Product and Solutions
2.6.4 Autolus Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Autolus Therapeutics Recent Developments and Future Plans
2.7 Aurora BioPharma
2.7.1 Aurora BioPharma Details
2.7.2 Aurora BioPharma Major Business
2.7.3 Aurora BioPharma CAR T-Cell Therapy Product and Solutions
2.7.4 Aurora BioPharma CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Aurora BioPharma Recent Developments and Future Plans
2.8 Sorrento Therapeutics
2.8.1 Sorrento Therapeutics Details
2.8.2 Sorrento Therapeutics Major Business
2.8.3 Sorrento Therapeutics CAR T-Cell Therapy Product and Solutions
2.8.4 Sorrento Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sorrento Therapeutics Recent Developments and Future Plans
2.9 Mustang Bio
2.9.1 Mustang Bio Details
2.9.2 Mustang Bio Major Business
2.9.3 Mustang Bio CAR T-Cell Therapy Product and Solutions
2.9.4 Mustang Bio CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Mustang Bio Recent Developments and Future Plans
2.10 Bluebird Bio
2.10.1 Bluebird Bio Details
2.10.2 Bluebird Bio Major Business
2.10.3 Bluebird Bio CAR T-Cell Therapy Product and Solutions
2.10.4 Bluebird Bio CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Bluebird Bio Recent Developments and Future Plans
2.11 Collectis
2.11.1 Collectis Details
2.11.2 Collectis Major Business
2.11.3 Collectis CAR T-Cell Therapy Product and Solutions
2.11.4 Collectis CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Collectis Recent Developments and Future Plans
2.12 Allogene Therapeutics
2.12.1 Allogene Therapeutics Details
2.12.2 Allogene Therapeutics Major Business
2.12.3 Allogene Therapeutics CAR T-Cell Therapy Product and Solutions
2.12.4 Allogene Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Allogene Therapeutics Recent Developments and Future Plans
2.13 Celyad
2.13.1 Celyad Details
2.13.2 Celyad Major Business
2.13.3 Celyad CAR T-Cell Therapy Product and Solutions
2.13.4 Celyad CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Celyad Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global CAR T-Cell Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 CAR T-Cell Therapy Players Market Share
3.2.2 Top 10 CAR T-Cell Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 CAR T-Cell Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global CAR T-Cell Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global CAR T-Cell Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global CAR T-Cell Therapy Revenue Market Share by Application (2016-2021)
5.2 CAR T-Cell Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America CAR T-Cell Therapy Revenue by Type (2016-2026)
6.2 North America CAR T-Cell Therapy Revenue by Application (2016-2026)
6.3 North America CAR T-Cell Therapy Market Size by Country
6.3.1 North America CAR T-Cell Therapy Revenue by Country (2016-2026)
6.3.2 United States CAR T-Cell Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada CAR T-Cell Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico CAR T-Cell Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe CAR T-Cell Therapy Revenue by Type (2016-2026)
7.2 Europe CAR T-Cell Therapy Revenue by Application (2016-2026)
7.3 Europe CAR T-Cell Therapy Market Size by Country
7.3.1 Europe CAR T-Cell Therapy Revenue by Country (2016-2026)
7.3.2 Germany CAR T-Cell Therapy Market Size and Forecast (2016-2026)
7.3.3 France CAR T-Cell Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom CAR T-Cell Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia CAR T-Cell Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy CAR T-Cell Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific CAR T-Cell Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific CAR T-Cell Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific CAR T-Cell Therapy Market Size by Region
8.3.1 Asia-Pacific CAR T-Cell Therapy Revenue by Region (2016-2026)
8.3.2 China CAR T-Cell Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan CAR T-Cell Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea CAR T-Cell Therapy Market Size and Forecast (2016-2026)
8.3.5 India CAR T-Cell Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia CAR T-Cell Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia CAR T-Cell Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America CAR T-Cell Therapy Revenue by Type (2016-2026)
9.2 South America CAR T-Cell Therapy Revenue by Application (2016-2026)
9.3 South America CAR T-Cell Therapy Market Size by Country
9.3.1 South America CAR T-Cell Therapy Revenue by Country (2016-2026)
9.3.2 Brazil CAR T-Cell Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina CAR T-Cell Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa CAR T-Cell Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa CAR T-Cell Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa CAR T-Cell Therapy Market Size by Country
10.3.1 Middle East & Africa CAR T-Cell Therapy Revenue by Country (2016-2026)
10.3.2 Turkey CAR T-Cell Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia CAR T-Cell Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE CAR T-Cell Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global CAR T-Cell Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global CAR T-Cell Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market CAR T-Cell Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global CAR T-Cell Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global CAR T-Cell Therapy Revenue Market Share by Region (2021-2026)
Table 6. Celgene (Juno Therapeutics) Corporate Information, Head Office, and Major Competitors
Table 7. Celgene (Juno Therapeutics) Major Business
Table 8. Celgene (Juno Therapeutics) CAR T-Cell Therapy Product and Solutions
Table 9. Celgene (Juno Therapeutics) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis CAR T-Cell Therapy Product and Solutions
Table 13. Novartis CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Gilead (Kite Pharma) Corporate Information, Head Office, and Major Competitors
Table 15. Gilead (Kite Pharma) Major Business
Table 16. Gilead (Kite Pharma) CAR T-Cell Therapy Product and Solutions
Table 17. Gilead (Kite Pharma) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Pfizer Corporate Information, Head Office, and Major Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer CAR T-Cell Therapy Product and Solutions
Table 21. Pfizer CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. CARsgen Therapeutics Corporate Information, Head Office, and Major Competitors
Table 23. CARsgen Therapeutics Major Business
Table 24. CARsgen Therapeutics CAR T-Cell Therapy Product and Solutions
Table 25. CARsgen Therapeutics CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Autolus Therapeutics Corporate Information, Head Office, and Major Competitors
Table 27. Autolus Therapeutics Major Business
Table 28. Autolus Therapeutics CAR T-Cell Therapy Product and Solutions
Table 29. Autolus Therapeutics CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Aurora BioPharma Corporate Information, Head Office, and Major Competitors
Table 31. Aurora BioPharma Major Business
Table 32. Aurora BioPharma CAR T-Cell Therapy Product and Solutions
Table 33. Aurora BioPharma CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Sorrento Therapeutics Corporate Information, Head Office, and Major Competitors
Table 35. Sorrento Therapeutics Major Business
Table 36. Sorrento Therapeutics CAR T-Cell Therapy Product and Solutions
Table 37. Sorrento Therapeutics CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Mustang Bio Corporate Information, Head Office, and Major Competitors
Table 39. Mustang Bio Major Business
Table 40. Mustang Bio CAR T-Cell Therapy Product and Solutions
Table 41. Mustang Bio CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Bluebird Bio Corporate Information, Head Office, and Major Competitors
Table 43. Bluebird Bio Major Business
Table 44. Bluebird Bio CAR T-Cell Therapy Product and Solutions
Table 45. Bluebird Bio CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Collectis Corporate Information, Head Office, and Major Competitors
Table 47. Collectis Major Business
Table 48. Collectis CAR T-Cell Therapy Product and Solutions
Table 49. Collectis CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Allogene Therapeutics Corporate Information, Head Office, and Major Competitors
Table 51. Allogene Therapeutics Major Business
Table 52. Allogene Therapeutics CAR T-Cell Therapy Product and Solutions
Table 53. Allogene Therapeutics CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Celyad Corporate Information, Head Office, and Major Competitors
Table 55. Celyad Major Business
Table 56. Celyad CAR T-Cell Therapy Product and Solutions
Table 57. Celyad CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global CAR T-Cell Therapy Revenue (USD Million) by Players (2019-2021)
Table 59. Global CAR T-Cell Therapy Revenue Share by Players (2019-2021)
Table 60. Breakdown of CAR T-Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. CAR T-Cell Therapy Players Head Office, Products and Services Provided
Table 62. CAR T-Cell Therapy Mergers & Acquisitions in the Past Five Years
Table 63. CAR T-Cell Therapy New Entrants and Expansion Plans
Table 64. Global CAR T-Cell Therapy Revenue (USD Million) by Type (2016-2021)
Table 65. Global CAR T-Cell Therapy Revenue Share by Type (2016-2021)
Table 66. Global CAR T-Cell Therapy Revenue Forecast by Type (2021-2026)
Table 67. Global CAR T-Cell Therapy Revenue by Application (2016-2021)
Table 68. Global CAR T-Cell Therapy Revenue Forecast by Application (2021-2026)
Table 69. North America CAR T-Cell Therapy Revenue by Type (2016-2021) & (USD Million)
Table 70. North America CAR T-Cell Therapy Revenue by Type (2021-2026) & (USD Million)
Table 71. North America CAR T-Cell Therapy Revenue by Application (2016-2021) & (USD Million)
Table 72. North America CAR T-Cell Therapy Revenue by Application (2021-2026) & (USD Million)
Table 73. North America CAR T-Cell Therapy Revenue by Country (2016-2021) & (USD Million)
Table 74. North America CAR T-Cell Therapy Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe CAR T-Cell Therapy Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe CAR T-Cell Therapy Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe CAR T-Cell Therapy Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe CAR T-Cell Therapy Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe CAR T-Cell Therapy Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe CAR T-Cell Therapy Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific CAR T-Cell Therapy Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific CAR T-Cell Therapy Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific CAR T-Cell Therapy Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific CAR T-Cell Therapy Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific CAR T-Cell Therapy Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific CAR T-Cell Therapy Revenue by Region (2021-2026) & (USD Million)
Table 87. South America CAR T-Cell Therapy Revenue by Type (2016-2021) & (USD Million)
Table 88. South America CAR T-Cell Therapy Revenue by Type (2021-2026) & (USD Million)
Table 89. South America CAR T-Cell Therapy Revenue by Application (2016-2021) & (USD Million)
Table 90. South America CAR T-Cell Therapy Revenue by Application (2021-2026) & (USD Million)
Table 91. South America CAR T-Cell Therapy Revenue by Country (2016-2021) & (USD Million)
Table 92. South America CAR T-Cell Therapy Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa CAR T-Cell Therapy Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa CAR T-Cell Therapy Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa CAR T-Cell Therapy Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa CAR T-Cell Therapy Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa CAR T-Cell Therapy Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa CAR T-Cell Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. CAR T-Cell Therapy Picture
Figure 2. Global CAR T-Cell Therapy Revenue Market Share by Type in 2020
Figure 3. Allogeneic
Figure 4. Autologous
Figure 5. CAR T-Cell Therapy Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Cancer Research Centers Picture
Figure 8. Others Picture
Figure 9. Global CAR T-Cell Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global CAR T-Cell Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global CAR T-Cell Therapy Revenue Market Share by Region (2016-2026)
Figure 12. Global CAR T-Cell Therapy Revenue Market Share by Region in 2020
Figure 13. North America CAR T-Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe CAR T-Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific CAR T-Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America CAR T-Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa CAR T-Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. CAR T-Cell Therapy Market Drivers
Figure 19. CAR T-Cell Therapy Market Restraints
Figure 20. CAR T-Cell Therapy Market Trends
Figure 21. Celgene (Juno Therapeutics) Recent Developments and Future Plans
Figure 22. Novartis Recent Developments and Future Plans
Figure 23. Gilead (Kite Pharma) Recent Developments and Future Plans
Figure 24. Pfizer Recent Developments and Future Plans
Figure 25. CARsgen Therapeutics Recent Developments and Future Plans
Figure 26. Autolus Therapeutics Recent Developments and Future Plans
Figure 27. Aurora BioPharma Recent Developments and Future Plans
Figure 28. Sorrento Therapeutics Recent Developments and Future Plans
Figure 29. Mustang Bio Recent Developments and Future Plans
Figure 30. Bluebird Bio Recent Developments and Future Plans
Figure 31. Collectis Recent Developments and Future Plans
Figure 32. Allogene Therapeutics Recent Developments and Future Plans
Figure 33. Celyad Recent Developments and Future Plans
Figure 34. Global CAR T-Cell Therapy Revenue Share by Players in 2020
Figure 35. CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players CAR T-Cell Therapy Revenue Market Share in 2020
Figure 37. Global Top 10 Players CAR T-Cell Therapy Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global CAR T-Cell Therapy Revenue Share by Type in 2020
Figure 40. Global CAR T-Cell Therapy Market Share Forecast by Type (2021-2026)
Figure 41. Global CAR T-Cell Therapy Revenue Share by Application in 2020
Figure 42. Global CAR T-Cell Therapy Market Share Forecast by Application (2021-2026)
Figure 43. North America CAR T-Cell Therapy Sales Market Share by Type (2016-2026)
Figure 44. North America CAR T-Cell Therapy Sales Market Share by Application (2016-2026)
Figure 45. North America CAR T-Cell Therapy Revenue Market Share by Country (2016-2026)
Figure 46. United States CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe CAR T-Cell Therapy Sales Market Share by Type (2016-2026)
Figure 50. Europe CAR T-Cell Therapy Sales Market Share by Application (2016-2026)
Figure 51. Europe CAR T-Cell Therapy Revenue Market Share by Country (2016-2026)
Figure 52. Germany CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific CAR T-Cell Therapy Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific CAR T-Cell Therapy Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific CAR T-Cell Therapy Revenue Market Share by Region (2016-2026)
Figure 60. China CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America CAR T-Cell Therapy Sales Market Share by Type (2016-2026)
Figure 67. South America CAR T-Cell Therapy Sales Market Share by Application (2016-2026)
Figure 68. South America CAR T-Cell Therapy Revenue Market Share by Country (2016-2026)
Figure 69. Brazil CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa CAR T-Cell Therapy Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa CAR T-Cell Therapy Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa CAR T-Cell Therapy Revenue Market Share by Country (2016-2026)
Figure 74. Turkey CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE CAR T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の筋骨格系障害幹細胞治療市場 2021：企業別、地域別、種類・用途別 The Musculoskeletal Disorder Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…- 世界の筋骨格障害幹細胞療法市場予測（～2024年） Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. This report studies on the Musculoskeletal Disorder Stem Cell Therapy. Scope of the Report: The global Musculoskeletal Disorder Stem Cell Therapy market is valued at xx million USD in 2018 and is expected to reach…
- 世界の細胞治療処理市場 2021：企業別、地域別、種類・用途別 The Cell therapy Processing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界のNK細胞療法市場予測（～2024年）：企業別、地域別、種類・用途別 Description Scope of the Report: The global NK Cell Therapy market is valued at 222.5 million USD in 2018 and is expected to reach 395.4 million USD by the end of 2024, growing at a CAGR of 15.5% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…
- 世界の細胞療法プロセッシング市場予測（～2024年）：企業別、地域別、種類・用途別 Cell therapy is the transplantation of human cells to replace or repair damaged tissue or cells. With new technologies and innovative products, many different types of cells can be used as part of a therapy or a treatment for a variety of diseases and conditions. Scope of the Report: The global Cell…